Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by noodleyon Nov 28, 2010 6:50am
373 Views
Post# 17767452

RE: WE NEED SOME NEWS!!!!!!!!

RE: WE NEED SOME NEWS!!!!!!!!at this point, cash, any news or a "crumb" won't do it - we need red meat.  FDA powwow is three weeks tomorrow.  sss has to hand in the presnetation a week tomorrow.  so...one would think...that if any material change is in the works - something that will affect the FDA deal - we'll be getting a meaty nr this week.  oh...and i get why chloe would excercise options on 19 may.....but why would it be reported on 25 nvember?  does that mean anything?
Bullboard Posts